Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
31
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
62%
ALSO IN XBI
XBI
138
HOLDINGS
23%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 1.8% | 1.4% | 1.4% |
|
NEUROCRINE BIOSCIENCES INC | 1.4% | 1.3% | 1.3% |
|
PTC THERAPEUTICS INC | 1.4% | 1.3% | 1.3% |
 |
ALKERMES PLC | 1.3% | 1.8% | 1.3% |
|
INCYTE CORP | 2.2% | 1.1% | 1.1% |
FTXH Overweight Relative to XBI
|
ELI LILLY & CO | 7.7% |
|
MERCK & CO. INC. | 6.8% |
|
JOHNSON & JOHNSON | 6.8% |
|
BRISTOL-MYERS SQUIBB CO | 6.4% |
|
ABBVIE INC | 5.8% |
|
VIATRIS, INC. | 3.8% |
|
CARDINAL HEALTH INC | 3.6% |
|
PFIZER INC | 3.4% |
|
BIOGEN IDEC INC | 2.6% |
|
JAZZ PHARMACEUTICALS PLC | 2.5% |
FTXH Underweight Relative to XBI
|
REVOLUTION MEDICINES, INC. | -1.8% |
|
BEAM THERAPEUTICS, INC. | -1.4% |
|
VERACYTE INC | -1.4% |
|
CYTOKINETICS INC | -1.4% |
|
NUVALENT, INC. CLASS A | -1.4% |
|
APOGEE THERAPEUTICS, INC. | -1.3% |
|
NATERA INC | -1.3% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.3% |
|
SCHOLAR ROCK HOLDING CORP. | -1.2% |
|
CRISPR THERAPEUTICS AG | -1.2% |